According to the latest available data, there were around **** suicide deaths per 100,000 population in the United States in 2022. Suicide remains one of the leading causes of death in the U.S. highlighting the need for awareness and prevention. The suicide rate in the U.S. has risen for both men and women in recent years but remains over ***** times higher for men. Hospitalizations In 2021, there were around ******* adults hospitalized in the U.S. after a suicide attempt. Although the suicide rate among men is significantly higher than among women, there are more hospitalizations after suicide attempts for women than for men. In 2019, there were ******* such hospitalizations among women and ******* hospitalizations among men. Public opinionSuicide can be a divisive topic that involves religious and political views. Recent data shows that ** percent of the U.S. population believes suicide is morally wrong, while ** percent believe it to be morally acceptable. However, only ** percent of adults believe it is “very important” to invest public dollars in the prevention of suicide.

Since the 1950s, the suicide rate in the United States has been significantly higher among men than women. In 2022, the suicide rate among men was almost four times higher than that of women. However, the rate of suicide for both men and women has increased gradually over the past couple of decades. Facts on suicide in the United States In 2022, the rate of suicide death in the United States was around 14 per 100,000 population. The suicide rate in the U.S. has generally increased since the year 2000, with the highest rates ever recorded in the years 2018 and 2022. In the United States, death rates from suicide are highest among those aged 45 to 64 years and lowest among younger adults aged 15 to 24. The states with the highest rates of suicide are Montana, Alaska, and Wyoming, while New Jersey and Massachusetts have the lowest rates. Suicide among men In 2023, around 4.5 percent of men in the United States reported having serious thoughts of suicide in the past year. Although this rate is lower than that of women, men still have a higher rate of suicide death than women. One reason for this may have to do with the method of suicide. Although firearms account for the largest share of suicide deaths among both men and women, firearms account for almost 60 percent of all suicides among men and just 35 percent among women. Suffocation and poisoning are the other most common methods of suicide among women, with the chances of surviving a suicide attempt from these methods being much higher than surviving an attempt by firearm. The age group with the highest rate of suicide death among men is by far those aged 75 years and over.

Linkages between climate and mental health are often theorized but remain poorly quantified. In particular, it is unknown whether suicide, a leading cause of death globally, is systematically affected by climatic conditions. Using multiple decades of comprehensive data from both the US and Mexico, we find that suicide rates rise 0.7% in US counties and 2.1% in Mexican municipalities for a 1C increase in monthly average temperature. This effect is similar in hotter versus cooler regions and has not diminished over time, indicating limited historical adaptation. Analysis of depressive language in >600 million social media updates further suggests that mental wellbeing deteriorates during warmer periods. We project that unmitigated climate change (RCP8.5) could result in a combined 9-40 thousand additional suicides (95% CI) across the US and Mexico by 2050, representing an change in suicide rates comparable to the estimated impact of economic recessions, suicide prevention programs, or gun restriction laws.

In March 2025, an estimated 1,254 people committed suicide in South Korea, a significant increase from the previous month. South Korea has the highest suicide rate among the member countries of the Organization for Economic Cooperation and Development (OECD).

New Mexico was the state with the highest rate of suicidal death among adolescents in the U.S. in 2023, with around **** deaths per 100,000 adolescents. The overall suicide rate in the U.S. has increased over recent years. Suicide is more common among men than women, with rates among men almost **** times higher than among women. Risk factors Risk factors for suicide include mental disorders, such as depression, bipolar disorder, and personality disorders, as well as substance abuse. In fact, suicidal thoughts, plans to commit suicide, and suicide attempts are all more common among those with drug or alcohol dependence or abuse. In terms of suicides due to a known mental disorder, depression accounts for around ** percent of all such suicides. Methods Most suicides in the United States are carried out by firearms, however, the most common method of suicide differs from country to country. In 2022, over ****** suicides in the United States were conducted by firearms, or just over half of all suicides that year. Firearms are the most common means of suicide among both men and women in the United States, but suicide by poisoning is much more common among women than men.

In 2024, Japan reported 16.4 suicides per 100,000 inhabitants. The country's suicide rate resumed its downward trend after an unexpected surge in recent years, likely connected to the COVID-19 pandemic. What are the reasons behind Japan’s high suicide rates?  While the majority of suicides in Japan stemmed from health reasons, existential concerns and problems directly related to work also accounted for thousands of self-inflicted deaths in the past years. One of the most profound issues faced by employees in Japan leading to self-harm is exhaustion. “Karoshi,” or death by overwork, is a well-known phenomenon in Japanese society. In addition to physical fatigue, karoshi may be precipitated by mental stress resulting from employment. Occupational stress or overwork-induced suicide is referred to as “karojisatsu (overwork suicide)” in Japan. Which demographic groups are affected? Although *************** are frequently depicted as the most at-risk demographic for suicide in Japan, the increasing occurrence of suicides among the elderly people and schoolchildren is causing concern. Bullying, isolation, and the lack of a proficient mental healthcare system can be additional factors contributing to the country’s high suicide rates among all age groups.

Number of suicides and suicide rates, by sex and age, in England and Wales. Information on conclusion type is provided, along with the proportion of suicides by method and the median registration delay.

Among men in the United States, those aged 75 years and older have the highest death rate from suicide among all age groups. In 2022, the suicide death rate among men aged 75 years and older was 43.9 per 100,000 population. In comparison, the death rate from suicide among men aged 25 to 44 years was 29.6 per 100,000. Suicide is a significant problem in the United States, with rates increasing over the past decade. Suicide among men In the United States, the suicide rate among men is almost four times higher than that of women. In 2022, the rate of suicide among U.S. men was 23 per 100,000 population, the highest rate recorded over the past 70 years. Firearms account for the vast majority of suicide deaths among men, accounting for around 60 percent of male suicides in 2021. The reasons why U.S. men have higher rates of suicide than women are complex and not fully understood, but may have to do with the more violent means by which men carry out suicide and the stigma around seeking help for mental health issues. Suicide among women Although the suicide rate among women in the U.S. is significantly lower than that of men, the rate of suicide among women has increased over the past couple of decades. Among women, those aged 45 to 64 years have the highest death rates due to suicide, followed by women 25 to 44 years old. Interestingly, the share of women reporting serious thoughts of suicide in the past year is higher than that of men, with around 5.5 percent of U.S. women reporting such thoughts in 2023. Similarly to men, firearms account for most suicide deaths among women, however suffocation and poisoning account for a significant share of suicides among women. In 2021, around 35 percent of suicides among women were carried out by firearms, while suffocation and poisoning each accounted for around 28 percent of suicide deaths.

Suicide IRR for BFP participation in the matched and original cohorts from 2004–2015.

ATT of suicide for BFP participation in the original cohort from 2004–2015.

Bangladesh suicide rate for 2021 was 2.81, a 0% increase from 2020.

<ul style='margin-top:20px;'>

<li>Bangladesh suicide rate for 2020 was <strong>2.81</strong>, a <strong>8.77% decline</strong> from 2019.</li>
<li>Bangladesh suicide rate for 2019 was <strong>3.08</strong>, a <strong>0.65% increase</strong> from 2018.</li>
<li>Bangladesh suicide rate for 2018 was <strong>3.06</strong>, a <strong>0.97% decline</strong> from 2017.</li>
</ul>Suicide mortality rate is the number of suicide deaths in a year per 100,000 population. Crude suicide rate (not age-adjusted).

Adjusted estimated differences in country-level monthly suicide rates per 100,000 population during COVID-19 pandemic compared to same months in the pre-pandemic periods.

Background The coronavirus disease 2019 (COVID-19) pandemic is an unprecedented global health crisis that may cause mental health problems and heighten suicide risk. We investigated the impact of the COVID-19 pandemic on trends in suicide attempts and suicide deaths in New Taipei City, Taiwan. Methods The current study used the official daily data on suicide attempts and deaths in New Taipei City, Taiwan (4 million inhabitants) between 2015 and 2020 from the Taiwan National Suicide Prevention Reporting System. Interrupted time-series (ITS) analyses with parameters corrected by the estimated autocorrelations were applied on weekly aggregated data to examine whether the suicide trends during the early COVID-19 pandemic (late January to July 2020) deviated from previous trends (January 2015 to late January 2020). The impact due to the suicide prevention policy change was also examined (since August 2020). Results ITS analyses revealed no significant increases in both mean and trend on weekly suicide deaths during the COVID-19 pandemic and after the policy change. In contrast, there was a significant increasing trend in weekly suicide attempts since the COVID-19 outbreak at the rate of 1.54 attempts per week (95% confidence interval 0.49–2.60; p = 0.004). Sex difference analysis revealed that, however, this increasing trend was observed only in females not in males. Conclusions The COVID-19 pandemic has different impacts on suicides attempts and deaths during the early pandemic in New Taipei City, Taiwan. The COVID-19 outbreak drastically increased the trend of suicide attempts. In contrast, the number of suicide deaths had remained constant in the investigated periods.

Anti-Suicide Drugs Market Outlook

The global anti-suicide drugs market size was valued at approximately USD 3.5 billion in 2023 and is projected to reach nearly USD 6.1 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.2% over the forecast period. This growth is primarily driven by increasing awareness of mental health issues, greater access to mental health care, and advancements in pharmacological therapies targeted toward reducing suicide rates. The rising prevalence of mental disorders such as depression, schizophrenia, and bipolar disorder has fueled the demand for effective anti-suicide medications. These factors, along with the proactive steps taken by governments and non-governmental organizations to promote mental health awareness, are significant contributors to market growth.

One of the key growth factors for the anti-suicide drugs market is the increasing burden of mental health disorders globally. According to the World Health Organization, close to 800,000 people die due to suicide every year, and mental disorders are a significant risk factor. This alarming statistic highlights the urgent need for effective treatments that can mitigate these risks. The growing prevalence of conditions such as depression and anxiety disorders, which are often linked to suicidal tendencies, has led to a higher demand for therapeutic interventions. Pharmaceutical companies are heavily investing in the research and development of innovative drug formulations to cater to this burgeoning demand, driving market growth.

Advancements in pharmacotherapy have significantly contributed to the growth of the anti-suicide drugs market. The development of novel drugs with improved efficacy and fewer side effects has led to increased adoption among healthcare professionals and patients. For instance, NMDA antagonists have shown promising results in reducing suicidal ideation, offering new hope for patients who have not responded well to traditional antidepressants. Moreover, the integration of personalized medicine and pharmacogenomics in psychiatric treatment is allowing for more tailored therapeutic approaches, enhancing the effectiveness of anti-suicide drugs. Such technological advancements are propelling the market forward, as they provide better clinical outcomes and improve patient quality of life.

Societal changes and governmental initiatives are also playing a crucial role in the growth of the anti-suicide drugs market. Many countries have recognized the importance of mental health as an integral part of public health and are implementing strategies and policies to address it. Campaigns aimed at reducing the stigma associated with mental health issues are encouraging more individuals to seek help, thus increasing the demand for psychiatric medications. Additionally, the availability of mental health services is improving, with more funding being allocated to mental health care infrastructure. These efforts are expected to create a supportive environment for market expansion, as they facilitate greater access to treatment options.

Anti depressant Drugs play a pivotal role in the treatment of depression, which is a major risk factor for suicide. These medications work by balancing chemicals in the brain that affect mood and emotions, thereby reducing symptoms of depression and anxiety. The development of newer antidepressants with improved efficacy and fewer side effects has been a significant advancement in mental health care. These drugs are often the first line of treatment for individuals experiencing depressive episodes, making them an essential component of anti-suicide strategies. As research continues, the potential for even more effective antidepressant therapies grows, offering hope for those struggling with mental health challenges.

From a regional perspective, North America holds the largest share of the anti-suicide drugs market, attributed to the high awareness of mental health issues, a well-established healthcare system, and the presence of major pharmaceutical companies. The Asia Pacific region is anticipated to witness the fastest growth during the forecast period, driven by an increasing focus on mental health, rising healthcare expenditures, and supportive government initiatives. Europe continues to be a significant contributor to the market, supported by robust healthcare policies and active engagement in mental health awareness campaigns. In contrast, Latin America and the Middle East & Africa are expected to show moderate growth due to emerging healthcare infrastructures and growing aware

South Korea currently has the highest overall suicide rate among OECD countries worldwide. The suicide rate among women in South Korea is significantly higher than that of women in any other country. Nevertheless, suicide is commonly more prevalent among men than women. Suicide in the U.S. The suicide rate in the United States has risen since the year 2000. As of 2022, there were around **** deaths from suicide per 100,000 population. The suicide rate among men in the U.S. is over ***** times what it is for females, a considerable and troubling difference. The suicide rate among men increases with age, with the highest rates found among men aged 75 years and older. Adolescent suicide Adolescent suicide is always a serious and difficult topic. A recent survey found that around ** percent of female high school students in the United States had seriously considered attempting suicide in the past year, compared to ** percent of male students. On average, there are around ** suicide deaths among adolescents per 100,000 population in the United States. The states with the highest rates of adolescent suicide include New Mexico, Idaho, and Oklahoma.

Anti Suicide Drug Market Outlook

The global anti-suicide drug market size was valued at approximately USD 3.5 billion in 2023 and is projected to reach USD 5.8 billion by 2032, growing at a CAGR of 5.2% during the forecast period. The growth of this market is driven by escalating awareness about mental health issues, the increasing prevalence of psychiatric disorders, and significant advancements in pharmaceutical research and development.

One of the primary growth factors in the anti-suicide drug market is the rising awareness and de-stigmatization of mental health issues. As more people recognize mental health as an essential component of overall well-being, and as stigma diminishes, there is a corresponding increase in the number of individuals seeking treatment. This shift has led to greater demand for effective pharmaceutical interventions. Additionally, governments and healthcare organizations worldwide are launching initiatives and campaigns to promote mental health awareness, which further propels the market's growth.

Another significant driver is the increasing prevalence of psychiatric disorders such as major depressive disorder, bipolar disorder, and schizophrenia. The World Health Organization (WHO) estimates that more than 264 million people suffer from depression globally, and the figures are expected to rise. This surge results in a higher necessity for anti-suicide drugs, as untreated or poorly managed psychiatric conditions can lead to suicidal ideation and attempts. Consequently, pharmaceutical companies are focusing on developing new and more effective drugs to meet this growing demand.

Technological advancements and innovations in pharmaceutical research and development significantly contribute to the market's growth. Companies are investing in developing novel therapeutics with improved efficacy and safety profiles. Emerging treatments, such as NMDA antagonists, show promise in treating suicidal ideation more rapidly than traditional antidepressants or antipsychotics. Furthermore, precision medicine and personalized treatment approaches are becoming increasingly prevalent, enabling more tailored and effective interventions for individuals at risk of suicide.

From a regional perspective, North America dominates the anti-suicide drug market owing to the high prevalence of psychiatric disorders, advanced healthcare infrastructure, and proactive government initiatives. However, regions such as Asia Pacific are expected to demonstrate the highest growth rates, driven by increasing awareness, improving healthcare systems, and rising incidences of mental health conditions. Europe also holds a significant market share due to the presence of key pharmaceutical companies and widespread mental health awareness campaigns.

Drug Type Analysis

In the anti-suicide drug market, several drug types are utilized to manage and mitigate suicidal ideation and attempts. Antidepressants constitute the largest segment due to their widespread use in treating major depressive disorders, which is a significant risk factor for suicide. These drugs work by balancing chemicals in the brain that affect mood and emotions, thereby reducing symptoms of depression that can lead to suicidal thoughts. SSRIs (Selective Serotonin Reuptake Inhibitors) and SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors) are among the most commonly prescribed antidepressants, given their efficacy and relatively favorable side effect profiles.

Antipsychotics are another critical segment in the anti-suicide drug market, primarily used to treat schizophrenia and bipolar disorder, both of which are associated with high suicide rates. These medications help manage symptoms such as hallucinations, delusions, and severe mood swings, reducing the likelihood of suicidal behavior. Atypical antipsychotics, in particular, are favored due to their improved safety and efficacy compared to older generation drugs.

Benzodiazepines, known for their sedative and anxiolytic effects, are often used in acute settings to manage severe anxiety and agitation, which can be precipitants of suicidal behavior. While not typically used as long-term solutions due to risks of dependency and abuse, they play a crucial role in short-term crisis intervention. The effectiveness of benzodiazepines in calming acute episodes makes them an essential tool in emergency psychiatric care.

NMDA (N-Methyl-D-Aspartate) antagonists are emerging as a promising segment within the market. These drugs, such as ketamine and its derivatives, have demonstrated

In 2023, the suicide rate in South Korea was particularly high among the elderly population over the age of **, with **** deaths per 100,000 population. The overall suicide rate among people aged 10 to 79 years increased compared to the previous year. Suicide was the leading cause of death among people aged 10 to 39 years. Suicide among the elderlySouth Korea has the highest suicide rate in the Organisation for Economic Co-operation and Development (OECD). One driving factor for suicide among the elderly is poverty. Almost half of the senior citizens in the country live with less than half the median disposable income. Many do not want to become a financial burden for their families and end up committing suicide as a result of not being able to support themselves.Suicide prevention Since the South Korean government implemented its initial suicide prevention program in 2004, numerous measures have been put in place to address the alarmingly high suicide rate. However, these efforts have not been very successful. Despite an increase in the annual budget for suicide prevention, it still remains significantly lower compared to international standards. If you are having suicidal thoughts, or you know someone who is, it is essential to seek help. Many countries have suicide crisis or prevention lines that offer free advice and support in such situations. If you live in the United States, you can reach the Suicide & Crisis Lifeline by simply calling *** to receive free and confidential support ****. If you live in South Korea you can call the suicide prevention hotline ***.

Description of nonbeneficiaries (non-BFP) and beneficiaries of the BFP in the original and matched cohorts from 2004 to 2015.

Introduction

Global Mental Health Apps Market Size is expected to be worth around US$ 26.2 billion by 2033 from US$ 6.3 billion in 2023, growing at a CAGR of 15.3% during the forecast period 2024 to 2033. In 2023, North America held over 38.7% market share, reaching a revenue total of US$ 2.4 Billion.

Advancements in smartphone technology are driving growth in the mental health apps market by facilitating easier identification of mental health issues. The widespread adoption of smartphones further supports this market expansion, along with a significant increase in the installation of mental health apps, particularly during the COVID-19 pandemic. These factors have collectively accelerated the development of the market.

There has been a shift away from traditional care models towards personalized mental health solutions offered by apps. These apps, which cater to needs ranging from meditation to managing anxiety and depression, play a crucial role in supporting psychological well-being and promoting a healthier, less stressful lifestyle. Moreover, the rising suicide rates have spurred the growth of the mental health apps industry. This growth is fueled by increasing awareness of mental health issues and the urgent need for easily accessible support options.

Mental health apps offer convenient early intervention tools such as self-assessment features and private counseling, focusing on user confidentiality and privacy. This emphasis on privacy encourages individuals to seek help for suicidal tendencies and various mental health conditions, further propelling the industry's expansion.

Approximately 19.86% of American adults, nearly 50 million individuals, are affected by mental illnesses. Of these, 4.91% experience severe mental health conditions. The prevalence of adult mental illness varies significantly across states, with New Jersey having the lowest rate at 16.37% and Utah the highest at 26.86%. According to the Substance Abuse and Mental Health Services Administration (SAMHSA), Any Mental Illness (AMI) encompasses diagnosable mental, behavioral, or emotional disorders that do not include developmental or substance use disorders, covering conditions from mild to severe.

Regarding substance use, about 7.74% of adults in the U.S. reported having a substance use disorder in the past year, with 2.97% reporting an illicit drug use disorder and 5.71% an alcohol use disorder. The state prevalence of substance use disorders among adults ranges from 5.98% in Florida to 12.30% in the District of Columbia.